Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride and Tamsulosin in Asian Men With BPH
NCT01534351Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Aug 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of finasteride in benign prostatic hyperplasia (BPH), sponsored by Merck & Co.. Started Aug 2013; status: terminated.
02
Drugs
finasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01534351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534351.